Enovate Biolife Pvt Ltd   Report issue

For profit
Founded: Mumbai India (1993)

Organization Overview

First Clinical Trial
2011
NCT01546662
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Distribuidora Biolife SA de CV | Enovate Biolife Pvt Ltd | INNN-MVS Department of Nuclear Medicine

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 5
  • # of Trial APIs: 8